Severe Psoriasis Market Is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Key Companies – Bristol Myers Squibb, Arcutis Biotherapeutics, AbbV

Advertisements
DelveInsight Business Research LLP
DelveInsight’s “Severe Psoriasis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Severe Psoriasis, historical and forecasted epidemiology as well as the Severe Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s “Severe Psoriasis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Severe Psoriasis, historical and forecasted epidemiology as well as the Severe Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. 

 

The Severe Psoriasis market report provides current treatment practices, emerging drugs, market share of individual therapies, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Severe Psoriasis market.

 

Severe Psoriasis Key Highlights: 

Key Companies included in the Psoriasis market include Bristol Myers Squibb, Arcutis Biotherapeutics, and many others.

Key Therapies included in the Psoriasis market includes Deucravacitinib, ARQ-151, ABBV-15, and many others 

Severe Psoriasis Overview

Psoriasis is a chronic, immune-mediated inflammatory skin disease characterized by the presence of papules and plaques occurring most commonly on the elbows, knees, scalp, and lower back, but is not limited to these areas. Psoriasis has both pediatric and adult-onset, with the former accounting for more cases. Plaques vary in terms of variable morphology, distribution, and severity. Psoriatic patients are frequently categorized into two groups: mild or moderate-to-severe psoriasis, depending on the clinical severity of the lesions, the percentage of affected body surface area, and the patient’s quality of life.

The five main types of psoriasis are plaque, guttate, inverse, pustular, and erythrodermic. Plaque psoriasis, also known as psoriasis vulgaris, makes up about 90% of cases. It typically presents as red patches with white scales on top. Areas of the body most commonly affected are the back of the forearms, shins, navel area, and scalp. Guttate psoriasis has drop-shaped lesions. Pustular psoriasis presents as small, noninfectious, pus-filled blisters. Inverse psoriasis forms red patches in skin folds. Erythrodermic psoriasis occurs when the rash becomes very widespread and can develop from any of the other types. Fingernails and toenails are affected in most people with psoriasis at some point in time. This may include pits in the nails or changes in nail color.

Severe Psoriasis Epidemiology Insights

According to the World Psoriasis Day Consortium, 125 million people worldwide (2-3% of the total population) have psoriasis.

According to Delveinsight’s estimates, the total prevalent population of psoriasis in the seven major markets will reach 17,373,980 cases by 2032. 

A total of 7MM prevalent cases of psoriasis in 2021 were 273,911 in the pediatric population and 15,100,161 in the adult population.  The US accounted for the maximum number of psoriasis cases in  2021.

Click here to learn more about the Severe Psoriasis Market Landscape

The Report Covers the Severe Psoriasis Epidemiology Segmented by:

Severe Psoriasis prevalent cases in pediatrics 

Severe Psoriasis prevalent cases in children

Severe Psoriasis prevalent cases based on the type 

Severe Psoriasis prevalent cases based on the location  

Severe Psoriasis Market Outlook 

The Severe Psoriasis market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Severe Psoriasis market trends by analyzing the impact of current Severe Psoriasis therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

 

This segment gives a thorough detail of the Severe Psoriasis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. 

 

According to DelveInsight, the Severe Psoriasis market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Severe Psoriasis Market

Bristol Myers Squibb 

Arcutis Biotherapeutics 

AbbVie 

And many others 

Severe Psoriasis Therapies Covered and Analyzed in the Report:

Deucravacitinib

ARQ-151

ABBV-15

And many others 

Learn more about the Key Companies and Emerging Therapies in the Severe Psoriasis 

Market

Table of Contents 

Key Insights 

Severe Psoriasis Introduction 

Executive Summary of Severe Psoriasis  

Disease Background and Overview

Epidemiology and patient population

Severe Psoriasis Emerging Therapies

Severe Psoriasis Market Outlook

Market Access and Reimbursement of Therapies

Market Drivers 

Market Barriers 

Appendix

Report Methodology

DelveInsight Capabilities

Disclaimer

Learn about the detailed offerings of the report @ Severe Psoriasis Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Daily Digest Signup

Daily business and market business news, business management tips, market research insights, and more.

Advertisements

Smart public opinion research for everyone.

%d bloggers like this: